English & Scottish HTAs Diverge On Sanofi’s Dupixent For Rare Skin Condition

 
• By Francesca Bruce
The answer is money
SMC decides whether like Sanofi's Dupixent drugs are value for money • Source: Shutterstock

More from Europe

More from Geography